<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent data suggest that myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> are organized hierarchically in terms of self-renewal and maturation of early progenitor cells, similar to <z:mpath ids='MPATH_458'>normal</z:mpath> myelopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mouse-repopulating leukemic stem cells usually co-express CD123 with CD34, but lack CD38 </plain></SENT>
<SENT sid="2" pm="."><plain>So far, however, little is known about expression of other markers and targets on these progenitors </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, expression of target antigens on CD34+/CD38- cells was analysed by multi-color flow cytometry in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (n = 18), <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, n = 6), <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>, n = 8) and systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> (SM, n = 9) </plain></SENT>
<SENT sid="4" pm="."><plain>The IL-3Ralpha chain (CD123) was found to be expressed on CD34+/CD38- cells in a majority of the patients in <z:hpo ids='HP_0000001'>all</z:hpo> disease categories </plain></SENT>
<SENT sid="5" pm="."><plain>Independent of the type of disease, the vast majority of these stem cells co-expressed aminopeptidase-N (CD13) and CD44 in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, the CD34+/CD38- progenitor cells expressed variable amounts of the target receptor CD33, c-kit (CD117) and AC133 (CD133) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, neoplastic stem cells in various myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> appear to express a similar phenotype including target antigens such as CD13, CD33 and CD44 </plain></SENT>
<SENT sid="8" pm="."><plain>Since many of these targets are not expressed on <z:hpo ids='HP_0000001'>all</z:hpo> stem cells in <z:hpo ids='HP_0000001'>all</z:hpo> patients, the elimination of the entire clone may require combinations of targeted antibodies or use of additional drugs </plain></SENT>
</text></document>